1. Home
  2. NKTR vs NAZ Comparison

NKTR vs NAZ Comparison

Compare NKTR & NAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • NAZ
  • Stock Information
  • Founded
  • NKTR 1990
  • NAZ 1992
  • Country
  • NKTR United States
  • NAZ United States
  • Employees
  • NKTR N/A
  • NAZ N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • NAZ Finance/Investors Services
  • Sector
  • NKTR Health Care
  • NAZ Finance
  • Exchange
  • NKTR Nasdaq
  • NAZ Nasdaq
  • Market Cap
  • NKTR 160.4M
  • NAZ 138.7M
  • IPO Year
  • NKTR 1994
  • NAZ N/A
  • Fundamental
  • Price
  • NKTR $0.72
  • NAZ $11.59
  • Analyst Decision
  • NKTR Strong Buy
  • NAZ
  • Analyst Count
  • NKTR 6
  • NAZ 0
  • Target Price
  • NKTR $4.92
  • NAZ N/A
  • AVG Volume (30 Days)
  • NKTR 1.9M
  • NAZ 18.3K
  • Earning Date
  • NKTR 05-08-2025
  • NAZ 01-01-0001
  • Dividend Yield
  • NKTR N/A
  • NAZ 3.69%
  • EPS Growth
  • NKTR N/A
  • NAZ N/A
  • EPS
  • NKTR N/A
  • NAZ N/A
  • Revenue
  • NKTR $87,248,000.00
  • NAZ N/A
  • Revenue This Year
  • NKTR N/A
  • NAZ N/A
  • Revenue Next Year
  • NKTR N/A
  • NAZ N/A
  • P/E Ratio
  • NKTR N/A
  • NAZ N/A
  • Revenue Growth
  • NKTR N/A
  • NAZ N/A
  • 52 Week Low
  • NKTR $0.43
  • NAZ $9.22
  • 52 Week High
  • NKTR $1.52
  • NAZ $11.37
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 54.57
  • NAZ 38.56
  • Support Level
  • NKTR $0.61
  • NAZ $11.47
  • Resistance Level
  • NKTR $0.74
  • NAZ $11.75
  • Average True Range (ATR)
  • NKTR 0.06
  • NAZ 0.14
  • MACD
  • NKTR 0.01
  • NAZ -0.05
  • Stochastic Oscillator
  • NKTR 81.79
  • NAZ 15.58

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to provide current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.

Share on Social Networks: